NCI Community Oncology Research Program (NCORP)

The NCI Community Oncology Research Program (NCORP) is a national network of cancer care investigators, providers, academia, and other organizations that care for diverse populations in health systems.

The DCP Community Oncology and Prevention Trials Research Group administers this program.

On this page

About NCORP

The program brings cancer clinical trials and control and delivery studies to individuals in their own communities, thereby generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities.

Visit the NCORP Website

Grantee Details

No matching Grants were found.

View All Grants

Clinical Trials

Status
Title Sort descending Intervention Sponsor Status
Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer Curcumin-based Gel, Dermatologic Complications Management, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration Gary Morrow Completed
Radiation Therapy in Treating Patients With Prostate Cancer 36.25 Gy IMRT, 51.6 Gy IMRT Radiation Therapy Oncology Group Completed
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Trastuzumab, Whole Breast Irradiation, Laboratory Biomarker Analysis National Cancer Institute (NCI) Active, not recruiting
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program Health Promotion and Education, Informational Intervention, Questionnaire Administration, Smoking Cessation Intervention Alliance for Clinical Trials in Oncology Recruiting
Reproductive Health Program in Patients With Cancer Standard practice related to reproductive heath, Training modules, algorithm, referral development ECOG-ACRIN Cancer Research Group Active, not recruiting
S0000B: Vitamin E and/or Selenium in Preventing Cataract and Age-Related Macular Degeneration in Men on SELECT SWOG-S0000 selenium, selenium placebo, vitamin E, vitamin E placebo SWOG Cancer Research Network Completed
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases assessment of therapy complications SWOG Cancer Research Network Completed
S0820, Adenoma and Second Primary Prevention Trial Eflornithine placebo & sulindac, Eflornithine placebo & sulindac placebo, Eflornithine plus sulindac, eflornithine & sulindac placebo SWOG Cancer Research Network Active, not recruiting
S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride assessment of therapy complications, psychosocial assessment and care, quality-of-life assessment SWOG Cancer Research Network Completed
S1105: Text-Messaging Intervention to Reduce Early Discontinuation of AI Therapy in Women With Early-Stage Breast Cancer Text message reminder SWOG Cancer Research Network Completed

News and Events